ChemoCentryx Inc
NASDAQ:CCXI
ChemoCentryx Inc
Cash from Financing Activities
ChemoCentryx Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ChemoCentryx Inc
NASDAQ:CCXI
|
Cash from Financing Activities
$8.2m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Financing Activities
-$211m
|
CAGR 3-Years
74%
|
CAGR 5-Years
59%
|
CAGR 10-Years
24%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Financing Activities
-$5.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Financing Activities
-$2.2B
|
CAGR 3-Years
31%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Financing Activities
-$625m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Financing Activities
-$1.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ChemoCentryx Inc's Cash from Financing Activities?
Cash from Financing Activities
8.2m
USD
Based on the financial report for Jun 30, 2022, ChemoCentryx Inc's Cash from Financing Activities amounts to 8.2m USD.
What is ChemoCentryx Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
24%
Over the last year, the Cash from Financing Activities growth was 120%. The average annual Cash from Financing Activities growth rates for ChemoCentryx Inc have been -54% over the past three years , 24% over the past five years .